| 날짜 |
제목 |
| 2026. 7. 16. |
Illumina expands Billion Cell Atlas program with new AI drug developers |
| 2026. 7. 9. |
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 |
| 2026. 7. 9. |
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer |
| 2026. 6. 23. |
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors |
| 2026. 6. 8. |
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution |
| 2026. 5. 28. |
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research |
| 2026. 5. 28. |
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research |
| 2026. 5. 21. |
David P. King elected to Illumina's Board of Directors |
| 2026. 5. 19. |
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact |
| 2026. 4. 30. |
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 |
| 2026. 4. 16. |
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows |
| 2026. 4. 14. |
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease |
| 2026. 4. 9. |
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 |
| 2026. 4. 2. |
Illumina Announces Changes to Board of Directors |
| 2026. 3. 18. |
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing |
| 2026. 3. 16. |
Illumina advances preventive genomics through strategic consortium with Veritas Genetics |
| 2026. 3. 5. |
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering |
| 2026. 2. 27. |
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida |
| 2026. 2. 25. |
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics |
| 2026. 2. 24. |
Illumina launches TruPath Genome, setting a new standard in genomic insight |
| 2026. 2. 23. |
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility |
| 2026. 2. 17. |
Illumina To Webcast Upcoming Investor Conference |
| 2026. 2. 5. |
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 |
| 2026. 2. 3. |
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally |
| 2026. 1. 30. |
Illumina completes acquisition of SomaLogic |
| 2026. 1. 20. |
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology |
| 2026. 1. 13. |
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery |
| 2026. 1. 13. |
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 |
| 2026. 1. 12. |
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 |
| 2026. 1. 8. |
Illumina Appoints Dr. Eric Green as Chief Medical Officer |
| 2026. 1. 6. |
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis |